Exclusive AES 2025 coverage on medication-resistant epilepsy, wearable EEG technology for seizure detection, treatment for refractory status epilepticus, and more.

An FDA memo is creating controversy after an official said the COVID-19 vaccine may have played a role in the deaths of at least 10 children.

For the first time in more than 3 decades, the United States did not take part in World AIDS Day on December 1.

HealthDay News — Faster amyloid accumulation is seen over time among individuals with obesity, according to a study presented at the annual meeting of the Radiological Society of North America, held ...

HealthDay News — Trajectories of long COVID have been identified, according to a study published online Nov. 17 in Nature Communications.

Longer PTR times during thrombectomy significantly increase the likelihood of death or hospice discharge and raise acute stroke care costs.

Measuring cognitive decline against premorbid ability removes racial differences after brain injury, indicating traditional test scores may reflect systemic bias.

Topline results from the RISE UP phase 3 trial demonstrated that mitapivat significantly improved hemoglobin response in patients with sickle cell disease.

Oral semaglutide did not significantly reduce disease progression in patients with early Alzheimer disease, according to results from two phase 3 trials.

Obstructive sleep apnea seems to be an independent risk factor for development of Parkinson disease, and early use of CPAP could modify risk.

A 25-item caregiver-reported tool reliably assesses physical, mental, and social health in children with Down syndrome and differentiates those with ASD.

Traumatic spinal cord injury significantly increases risk for chronic cardiovascular, neurologic, psychiatric, and endocrine disorders compared with uninjured adults.